These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29114703)

  • 1. Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C.
    Alboraie M; Schütte K; Khairy M; Elsharkawy M; Asem N; Elghamry F; Shalaby H; Esmat G; Malfertheiner P
    Saudi Med J; 2017 Nov; 38(11):1137-1142. PubMed ID: 29114703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.
    Alboraie M; Khairy M; Elsharkawy A; Elsharkawy M; Asem N; Abo El-Seoud AR; Elghamry FG; Esmat G
    Saudi J Gastroenterol; 2014; 20(3):170-4. PubMed ID: 24976280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.
    Alboraie MA; Afifi ME; Elghamry FG; Shalaby HA; Elshennawy GE; Abdelaziz AA; Shaheen MU; Abo El-Seoud AR
    Hepat Mon; 2013; 13(6):e10810. PubMed ID: 24046790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing ultrasound based transient elastography cutoffs for different stages of hepatic fibrosis and cirrhosis in Egyptian chronic hepatitis C patients.
    Elsharkawy A; Alboraie M; Fouad R; Asem N; Abdo M; Elmakhzangy H; Mehrez M; Khattab H; Esmat G
    Arab J Gastroenterol; 2017 Dec; 18(4):210-215. PubMed ID: 29187317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
    Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.
    Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Marczyńska M
    BMC Infect Dis; 2017 May; 17(1):361. PubMed ID: 28535787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of hepatocyte growth factor, Fas/CD95 and Endostatin for non-invasive assessment of hepatic fibrosis in biopsy-proven hepatitis C virus patients.
    Abdelgawad ME; El-Zakzok H; Salah M; El-Mezayen HA
    Infect Genet Evol; 2020 Nov; 85():104526. PubMed ID: 32890764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
    Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
    Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.
    Ito K; Kuno A; Ikehara Y; Sugiyama M; Saito H; Aoki Y; Matsui T; Imamura M; Korenaga M; Murata K; Masaki N; Tanaka Y; Hige S; Izumi N; Kurosaki M; Nishiguchi S; Sakamoto M; Kage M; Narimatsu H; Mizokami M
    Hepatology; 2012 Oct; 56(4):1448-56. PubMed ID: 22535703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate prediction of significant liver fibrosis using the Pentra score model in patients with chronic hepatitis C.
    Górka-Dynysiewicz J; Pazgan-Simon M; Zuwała-Jagiełło J
    Pol Arch Intern Med; 2020 Feb; 130(2):112-120. PubMed ID: 31922501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C.
    Ren Y; Liu M; Zhao J; Ren F; Chen Y; Li JF; Zhang JY; Qu F; Zhang JL; Duan ZP; Zheng SJ
    World J Gastroenterol; 2015 Oct; 21(39):11152-9. PubMed ID: 26494969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Lemoine M; Shimakawa Y; Nayagam S; Khalil M; Suso P; Lloyd J; Goldin R; Njai HF; Ndow G; Taal M; Cooke G; D'Alessandro U; Vray M; Mbaye PS; Njie R; Mallet V; Thursz M
    Gut; 2016 Aug; 65(8):1369-76. PubMed ID: 26109530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.